Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Nov;31(11):1703–1705. doi: 10.1128/aac.31.11.1703

Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis.

G Foulds 1, T J McBride 1, A K Knirsch 1, W J Rodriguez 1, W N Khan 1
PMCID: PMC175024  PMID: 3435118

Abstract

Infusions of 50 mg of sulbactam per kg per day and 400 mg of ampicillin per kg per day in divided doses to infants and children with bacterial meningitis produced levels in cerebrospinal fluid approximately one-third those in serum. Concentrations in cerebrospinal fluid of 5.5 micrograms of sulbactam per ml and 16.0 micrograms of ampicillin per ml declined within a few days of therapy to 1.9 microgram of sulbactam per ml and 5.2 micrograms of ampicillin per ml.

Full text

PDF
1703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aswapokee N., Neu H. C. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot (Tokyo) 1978 Dec;31(12):1238–1244. doi: 10.7164/antibiotics.31.1238. [DOI] [PubMed] [Google Scholar]
  2. Brown R. M., Wise R., Andrews J. M., Hancox J. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother. 1982 Apr;21(4):565–567. doi: 10.1128/aac.21.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. English A. R., Retsema J. A., Girard A. E., Lynch J. E., Barth W. E. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother. 1978 Sep;14(3):414–419. doi: 10.1128/aac.14.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foulds G., Knirsch A. K., Stankewich J. P., Weidler D. R. The parenteral kinetics of ampicillin/sulbactam in man. Int J Clin Pharmacol Res. 1985;5(2):79–86. [PubMed] [Google Scholar]
  5. Foulds G., Stankewich J. P., Marshall D. C., O'Brien M. M., Hayes S. L., Weidler D. J., McMahon F. G. Pharmacokinetics of sulbactam in humans. Antimicrob Agents Chemother. 1983 May;23(5):692–699. doi: 10.1128/aac.23.5.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hänninen P., Rossi T. Penetration of sulbactam into cerebrospinal fluid of patients with viral meningitis or without meningitis. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S609–S611. doi: 10.1093/clinids/8.supplement_5.s609. [DOI] [PubMed] [Google Scholar]
  7. Istre G. R., Conner J. S., Glode M. P., Hopkins R. S. Increasing ampicillin-resistance rates in Hemophilus influenzae meningitis. Am J Dis Child. 1984 Apr;138(4):366–369. doi: 10.1001/archpedi.1984.02140420032012. [DOI] [PubMed] [Google Scholar]
  8. Khan W., Ross S., Rodriguez W., Controni G., Saz A. K. Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA. 1974 Jul 15;229(3):298–301. [PubMed] [Google Scholar]
  9. Labia R., Lelievre V., Peduzzi J. Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899). Biochim Biophys Acta. 1980 Feb 14;611(2):351–357. doi: 10.1016/0005-2744(80)90071-6. [DOI] [PubMed] [Google Scholar]
  10. Nelson J. D. Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease? JAMA. 1974 Jul 15;229(3):322–324. [PubMed] [Google Scholar]
  11. ROgers H. J., Bradbrook I. D., Morrison P. J., Spector R. G., Cox D. A., Lees L. J. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. J Antimicrob Chemother. 1983 May;11(5):435–445. doi: 10.1093/jac/11.5.435. [DOI] [PubMed] [Google Scholar]
  12. Retsema J. A., English A. R., Girard A. E. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother. 1980 Apr;17(4):615–622. doi: 10.1128/aac.17.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Retsema J. A., English A. R., Girard A., Lynch J. E., Anderson M., Brennan L., Cimochowski C., Faiella J., Norcia W., Sawyer P. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S528–S534. doi: 10.1093/clinids/8.supplement_5.s528. [DOI] [PubMed] [Google Scholar]
  14. Rodríguez W. J., Khan W. N., Puig J., Feris J., Harmon S., Gold B. G., Ahmad S. Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S620–S629. doi: 10.1093/clinids/8.supplement_5.s620. [DOI] [PubMed] [Google Scholar]
  15. Schlech W. F., 3rd, Ward J. I., Band J. D., Hightower A., Fraser D. W., Broome C. V. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985 Mar 22;253(12):1749–1754. [PubMed] [Google Scholar]
  16. Stahl J. P., Bru J. P., Fredj G., Brammer K. W., Malleret M. R., Micoud M. Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S612–S616. doi: 10.1093/clinids/8.supplement_5.s612. [DOI] [PubMed] [Google Scholar]
  17. Stephenson W. P., Doern G., Gantz N., Lipworth L., Chapin K. Pharyngeal carriage rates of Haemophilus influenzae, type b and non-b, and prevalence of ampicillin-resistant Haemophilus influenzae among healthy day-care children in central Massachusetts. Am J Epidemiol. 1985 Nov;122(5):868–875. doi: 10.1093/oxfordjournals.aje.a114169. [DOI] [PubMed] [Google Scholar]
  18. Thornsberry C., Kirven L. A. Antimicrobial susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother. 1974 Nov;6(5):620–624. doi: 10.1128/aac.6.5.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tomeh M. O., Starr S. E., McGowan J. E., Jr, Terry P. M., Nahmias A. J. Ampicillin-resistant Haemophilus influenzae type B infection. JAMA. 1974 Jul 15;229(3):295–297. [PubMed] [Google Scholar]
  20. Whitby M., Finch R. Bacterial meningitis. Rational selection and use of antibacterial drugs. Drugs. 1986 Mar;31(3):266–278. doi: 10.2165/00003495-198631030-00004. [DOI] [PubMed] [Google Scholar]
  21. Wise R., Andrews J. M., Bedford K. A. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. J Antimicrob Chemother. 1980 Mar;6(2):197–206. doi: 10.1093/jac/6.2.197. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES